DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
DiaSorin | Saluggia
MeMed partners with Italy's DiaSorin to commercialize bacteria vs virus test | The Times of Israel
DiaSorin Inc. | DiaSorin
COVID-19 | Updates | DiaSorin
DiaSorin | Saluggia
DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-
DiaSorin - The Diagnostic Specialist
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking Alpha
Results | DiaSorin
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
Annual Financial Report
DiaSorin concludes acquisition of Luminex for $1.8bn
Liaison XL. Soluciones para el inmunodiagnóstico. - YouTube
DiaSorin Molecular Receives FDA Clearance for Reliable C. difficile Assay on LIAISON MDX Platform | Technology Networks
DiaSorin | LinkedIn
Minnesota State College Southeast - News, Events, and Updates
DiaSorin - The Diagnostic Specialist
REPORT ON THE REMUNERATION POLICY FOR THE YEAR 2022 AND REMUNERATION PAID IN THE YEAR 2021 OF DIASORIN S.p.A.
Italian biotech company DiaSorin says its Covid-19 tests can detect omicron variant - YouTube
Borsa: Milano recupera (-0,5%) con Mps, male Cnh e Diasorin - Notizie - Ansa.it
DiaSorin Spa Italy - DiaSorin Molecular
DiaSorin Molecular LLC | LinkedIn
Italian test maker DiaSorin puts down $1.8B for Luminex in diagnostics tie-up | Fierce Biotech
Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News
Annual Financial Report
Borsa: Milano frena ancora (-1,1%), pesano Diasorin e Stellantis - Notizie - Ansa.it
DiaSorin | Saluggia
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
DiaSorin
DiaSorin Molecular LLC | LinkedIn
DiaSorin Italia S.p.A. | DiaSorin
DiaSorin - The Diagnostic Specialist
Covid-19 Tests in America: DiaSorin Gets FDA Emergency-Use Rights - Bloomberg
DiaSorin | Saluggia
Annual Financial Report
DiaSorin Molecular LLC | LinkedIn
DiaSorin - The Diagnostic Specialist
DiaSorin | Saluggia
DiaSorin Completes $1.8bn Acquisition Of Luminex :: Medtech Insight
Diasorin heads to the US with $1.8bn Luminex deal | Evaluate
DiaSorin | Saluggia
DiaSorin | Saluggia
DiaSorin | LinkedIn
